{
  "meta": {
    "title": "Pharmacology_Mini_Test_2_Autocoids_Rs_Git",
    "url": "https://brainandscalpel.vercel.app/pharmacology-mini-test-2-autocoids-rs-git-602cddb8.html",
    "scrapedAt": "2025-11-30T07:33:16.934Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Bradykinin</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Histamine</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Leukotrienes</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostaglandin F2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24 year old woman presents to gynaecology department with severe pain during menses (dysmenorrhea). Her gynaecologist has advised her to take indomethacin during the same time. This drug may reduce her pain because it interferes with the production of which one of the following substances?</span></p>",
      "unique_key": "Q238031",
      "question_audio": null,
      "question_video": null,
      "map_id": 238031,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong>Prostaglandin F2 (PGF2) causes uterine contractions, which can result in painful menses (dysmenorrhea).</strong></li></ul><ul><li><u>Indomethacin can be used to treat dysmenorrhea by decreasing the production of PGF2</u> as it, along with aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), inhibit the enzyme cyclooxygenase (COX).</li></ul><ul><li><strong>Dysmenorrhoea in many women is associated with increased PG synthesis by the endometrium</strong>. This apparently induces uncoordinated uterine contractions which compress blood vessels causing uterine ischaemia and pain.</li></ul><ul><li><u>Aspirin group of drugs are highly effective in relieving dysmenorrhoea in most women.</u></li></ul><ul><li><strong><u>Uterus</u></strong></li><li>PGE2 and PGF2&alpha; are powerful uterine stimulants (contractor).</li></ul><ul><li>PGE2 causes softening of cervix (cervical ripening) during labour. Dinoprostone or misoprostol intravaginally are employed for cervical ripening during labour.</li></ul><ul><li>Carboprost (PGF2&alpha;) can be used to control post partum hemorrhage (contraction of uterus leads to compression of blood vessels resulting in decreased bleeding).</li></ul><ul><li><strong>PGs are responsible for pain during menstruation (</strong><strong>dysmenorrhoea</strong><strong>) and</strong><strong> NSAIDs like </strong><strong>mefenamic acid </strong><strong>are useful for relieving this pain.</strong></li></ul><ul><li><strong><u>Key takeaway</u></strong></li><li><strong>Indomethacin can be used to treat dysmenorrhea by decreasing the production of PGF2 as it, along with aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs), inhibit the enzyme cyclooxygenase (COX).</strong></li></ul>[Good to Know][Indomethacin]<p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number:200</p>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Dyslipidemia</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoglycemia</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketoacidosis</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Alkalosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45 year old male patient came to rheumatologist with history of ongoing treatment with an anti-rheumatoid arthritis drug. He was prescribed aspirin at anti-inflammatory doses. He also had history of type-II diabetes mellitus. Which of the following side effect of aspirin is to be very closely looked for diabetic patient when aspirin is given in anti-inflammatory dose?</span></p>",
      "unique_key": "Q238032",
      "question_audio": null,
      "question_video": null,
      "map_id": 238032,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<p><strong><u>Metabolic and other effects of high (antiinflammatory/toxic) doses </u></strong></p><ul><li><strong>High doses (3-5 g/day or 100 mg/kg/day) needed for anti-inflammatory action in rheumatoid arthritis</strong>/rheumatic fever produce several other effects.</li></ul><ul><li>Cellular metabolism is enhanced, especially in skeletal muscles, due to <u>uncoupling of oxidative phosphorylation.</u></li></ul><ul><li><strong>Glucose utilization is increased resulting in fall in blood glucose level (especially in diabetics); liver glycogen is depleted.</strong></li></ul><ul><li>Respiration is stimulated by direct action on respiratory centre as well as due to increased CO2 production.</li></ul><ul><li>Respiratory stimulation tends to washout CO2 and produce <strong>respiratory alkalosis.</strong> This is compensated by enhanced HCO3 - excretion by kidney. Most adults receiving 3-5 g/day stay in a state of compensated respiratory alkalosis.</li></ul><ul><li><strong>Dehydration occurs due to excess water loss in urine, sweating and hyperventilation</strong>. Most children manifest this phase during salicylate poisoning, while in adults it is seen only in late stages of poisoning.</li></ul><p><strong><u>Relationship between the dosage of aspirin and the pharmacologic and toxic effects of the drug.</u></strong></p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/PharmacoMiniII27112024/2E.jpg\"><p><u>Key takeaway</u></p><ul><li>At anti-inflammatory doses of aspirin, Glucose utilization is increased resulting in fall in blood glucose level (especially in diabetics); liver glycogen is depleted.</li></ul><p>[Must Know]</p><p>[Aspirin]</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 213-214</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfinpyrazone</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Piroxicam</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is useful in acute attack of gout?</span></p>",
      "unique_key": "Q238033",
      "question_audio": null,
      "question_video": null,
      "map_id": 238033,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong>NSAIDs and colchicine are highly effective in acute attack of gout whereas allopurinol and sulfinpyrazone are used for chronic gout.</strong></li></ul><p><strong><u>N</u><u>SAID</u><u>s</u></strong></p><ul><li><u>One of the strong anti-inflammatory drugs, e.g. naproxen, piroxicam, diclofenac, indomethacin or etoricoxib is given in relatively high and quickly repeated doses.</u></li><li>They are quite effective in terminating the attack, but may take 12-24 hours, while complete resolution takes 5-10 days.</li><li>Response is somewhat slower than with colchicine, but they are generally better tolerated.</li><li><strong>Majority of patients prefer NSAIDs over colchicine</strong>. Their strong anti-inflammatory (not uricosuric) action is responsible for the benefit.</li><li><strong>Naproxen and piroxicam specifically inhibit chemotactic migration of leucocytes into the inflamed joint.</strong></li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/PharmacoMiniII27112024/3E.jpg\"><p><strong><u>Pharmacotherapy of Gout:</u></strong></p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/PharmacoMiniII27112024/3E1.jpg\"><p><strong>Option A</strong>: Furosemide causes hyperuricemia and should be a avoided in patients with gout.</p><p><strong>Option B &amp; C</strong>: Allopurinol and sulfinpyrazone are used for chronic gout.</p><ul><li><strong><u>Key takeaway</u></strong></li><li><strong>NSAIDs and colchicine are highly effective in acute attack of gout. Piroxicam specifically inhibit chemotactic migration of leucocytes into the inflamed joint</strong></li></ul><p>[Must Know]</p><p>[Piroxicam]</p><p><strong><strong>Reference: </strong></strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 231</p>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">To cause fewer adverse effects</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">To slow down the progression of bone and cartilage destruction</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">To improve symptoms after one week of therapy</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">To completely cure the disease, after 2 to 4 months of therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52 year old woman recently diagnosed with mild rheumatoid arthritis started a therapy with nonsteroidal anti-inflammatory drugs (NSAIDs), but later, the physician decided to add a disease-modifying anti-rheumatic drug (DMARD) to the therapeutic regimen. Which of the following is most likely the main advantage of DMARDs over NSAIDs in the treatment of rheumatoid arthritis?</span></p>",
      "unique_key": "Q238034",
      "question_audio": null,
      "question_video": null,
      "map_id": 238034,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li>NSAIDs were once considered the first-line treatment of rheumatoid arthritis, but today <u>they are used only as needed to control pain because</u> <strong>it has been shown that they have little effect on bone and cartilage destruction.</strong></li><li>On the contrary, <strong>DMARDs can arrest, or at least slow down, the progression of the disease.</strong></li><li>They are slow-acting drugs, and <strong>their effect may take 6 weeks to 6 months to become evident.</strong></li><li>Therefore, DMARD treatment should not be delayed beyond 3 months of arthritis diagnosis for the majority of patients.</li><li><strong>Rheumatoid arthritis (RA) is an autoimmune multisystem disease. </strong></li><li><u>NSAIDs are used to provide symptomatic relief but exert no effect on the progression of the disease</u><u>.</u></li><li><u>Disease modifying anti rheumatoid drugs (DMARDs) slow the</u> <u>progression of disease but act slowly (takes 6 weeks to 6 months).</u></li><li>The onset of benefit with DMARDs takes a few months of regular treatment, and relapses occur at least a few months after cessation of therapy.</li><li><u>Rheumatoid arthritis </u><u>(RA) is an autoimmune disease in which there is joint inflammation, synovial proliferation and destruction of articular cartilage.</u></li><li>RA is a chronic progressive, crippling disorder with a waxing and waning course. <u>Multiple small joints of hands and feet are preferentially affected; deformities are produced as the disease progresses</u>.</li><li><strong>NSAIDs are the first line drugs which afford symptomatic relief in pain, swelling, morning stiffness, immobility, but do not arrest the disease process</strong>.</li></ul><p><strong><u>The goals of drug therapy in RA are:</u></strong></p><ul><li>Ameliorate pain, swelling and joint stiffness</li><li>Prevent articular cartilage damage and bony erosions</li><li>Preserve joint function and prevent deformity</li></ul><p><strong><u>Key takeaway</u></strong></p><ul><li>NSAIDs are the first line drugs which afford symptomatic relief in pain, swelling, morning stiffness, immobility<em>, but do not arrest the disease process. On the contrary, DMARDs can arrest, or at least slow down, the progression of the disease.</em></li></ul><p><strong>[Must Know]</strong></p><p><strong>[DMARDs]</strong></p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number:227-228</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Diclofenac</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetaminophen</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Fentanyl</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old man suffering from rheumatoid arthritis complained to his physician that his joint pain had increased recently despite current naproxen and hydroxychloroquine therapy. Which of the following drugs would be appropriate to add to the patient's therapy at this time?</span></p>",
      "unique_key": "Q238035",
      "question_audio": null,
      "question_video": null,
      "map_id": 238035,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong>Methotrexate is currently a first-line treatment for most patients with rheumatoid arthritis</strong> <strong>because </strong><ul><li><strong>High rate of response, </strong></li><li><strong>Relatively rapid onset of action (1 to 2 months) and </strong></li><li><strong>Long sustained efficacy.</strong></li></ul></li><li>This <strong>dihydrofolate reductase inhibitor has <u>prominent immunosuppressant </u>and <u>antiinflammatory property</u></strong>.</li><li>Beneficial effects in Rheumatoid arthritis are probably related to</li><li><u>Inhibition of cytokine production, chemotaxis and cell-mediated immune reaction.</u></li><li>Proliferation of immune-inflammatory cells is inhibited.</li><li><strong>Methotrexate</strong> is the <strong>DMARD of</strong> <strong>first choice and the standard treatment for most patients, including cases of juvenile Rheumatoid arthritis</strong></li><li><strong>Side effects</strong><ul><li><strong>Dose dependent progressive liver damage leading to cirrhosis</strong></li><li><strong>Incidence of chest infection</strong> is increased.</li><li><strong>Methotrexate</strong> is contraindicated in pregnancy, breast-feeding, liver disease, active infection, leucopenia and peptic ulcer.</li></ul></li></ul><p><strong>Option A, B</strong> : The <strong>patient was already receiving a nonsteroidal anti-inflammatory drug</strong>, so the addition of another drug of the same class would be of little value.</p><p><strong>Option D</strong> : <strong>Fentanyl is a powerful opioid drug</strong>. Opioid analgesics are used in rheumatoid arthritis only exceptionally, on an as-needed basis, when the pain is excruciating.</p><p><strong>Key Takeaway</strong></p><ul><li><strong>Methotrexate is currently a first-line treatment for most patients with rheumatoid arthritis because of beneficial profile especially in mild patients with RA.</strong></li></ul><p><strong>[Good to Know]</strong></p><p><strong>[Methotrexate]</strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 228</p>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetaminophen</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Ibuprofen</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylephrine</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55 year old man complained to his physician that a rash had appeared the previous day on his thorax and legs. The patient was recently diagnosed with hyperuricemia and had been receiving allopurinol for 2 weeks. The physician suspected the rash was due to the ongoing pharmacotherapy and decided to discontinue allopurinol and to start a treatment with probenecid. The physician should advise the patient not to concurrently use which of the following drugs?</span></p>",
      "unique_key": "Q238036",
      "question_audio": null,
      "question_video": null,
      "map_id": 238036,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong>Uricosuric drugs such as salicylates and probenecid compete with uric acid for these transport mechanisms.</strong></li><li>They have a paradoxical effect because, depending on dosage, they may either decrease or increase the elimination of uric acid.</li><li><u>Salicylates such as aspirin can completely antagonize the uricosuric action of probenecid.</u> This interaction probably involves several mechanisms, including competition for renal tubular transport.</li><li><strong><u>Adverse Effects of Aspirin</u></strong></li><li>Salicylates can cause <strong>dose dependent effects on acid base balance</strong>.</li><li><strong>Respiratory alkalosis occurs first characterized by </strong><strong>headache, vertigo, tinnitus, vomiting and hyperventilation </strong><strong>(salicylism).</strong></li><li>Aspirin can <strong>prolong bleeding time </strong>and should be used cautiously with Anti-coagulants.</li><li><strong>At therapeutic doses, it can cause hyperuricemia </strong>by decreasing the excretion of uric acid. It, therefore, should not be used in patients with gout.</li><li>It<strong> also decreases the uricosuric action of probenecid. </strong>At high doses (&gt;5 g/d), it increases the excretion of uric acid, but such high doses are not tolerated.</li><li>Aspirin is <strong>contraindicated in children </strong>(&lt;12 yrs old) <strong>due to increased risk of Reye's syndrome.</strong></li><li><strong><u>Contraindications of Aspirin:</u></strong></li><li><strong><u>Mnemonic :</u></strong><strong> [</strong><strong>BARS</strong><strong>]</strong></li></ul><p><strong>B</strong>leeding</p><p><strong>A</strong>sthma</p><p><strong>R</strong>enal disease (nephropathy)</p><p><strong>S</strong>tomach (Peptic ulcer)</p><ul><li><strong><u>Aspirin side effects:</u></strong></li><li><strong><u>Mnemonic :</u></strong><strong> [</strong><strong>ASPIRIN</strong><strong>]</strong></li></ul><p><strong>A</strong>llergic like reactions (urticaria)</p><p><strong>S</strong>usceptibility to bleeding</p><p><strong>P</strong>eptic ulcer</p><p><strong>I</strong>diosyncratic reactions</p><p><strong>R</strong>eye's syndrome</p><p>R<strong>I</strong>nging in ears (Tinnitus)</p><p><strong>N</strong>ephropathy</p><p><strong><u>Key Takeaway</u></strong></p><ul><li><strong>Salicylates such as aspirin can completely antagonize the uricosuric action of probenecid.</strong></li></ul><p><strong>[Must Know]</strong></p><p><strong><strong>[Aspirin]</strong></strong></p><p><strong>Reference: </strong>Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 214</p>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Liquid paraffin</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Bran</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Ispaghula</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Osmotic purgatives</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following purgative is associated with development of hypokalemia as an adverse effect when used for long term?</span></p>",
      "unique_key": "Q238037",
      "question_audio": null,
      "question_video": null,
      "map_id": 238037,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong>The repeated use of osmotic or saline purgatives causes hypokalemia and other fluid &amp; electrolyte disturbances.</strong></li><li><strong><u>Purgative abuse </u></strong></li><li>Purgatives are often self prescribed and taken without consulting a physician. Some individuals are obsessed with using purgatives regularly.</li><li>This may be the reflection of a psychological problem. Others use a purgative casually, obtain thorough bowel evacuation, and by the time the colon fills up for a proper motion (2-3 days) they get convinced that they are constipated and start taking the purgative regularly.</li><li><u>Chronic use of stimulant purgatives must be discouraged. Once the purgative habit forms, it is difficult to break.</u></li><li><strong><u>Drawbacks of purgative abuse are:</u></strong><ul><li>Fluid and electrolyte imbalance, especially hypokalaemia.</li><li>Steatorrhoea, malabsorption syndrome.</li><li>Protein losing enteropathy.</li><li>Spastic colitis.</li></ul></li></ul><p><strong>Option A</strong>: Liquid paraffin does not cause hypokalemia. Although, it can cause foreign body granuloma and lipid pneumonia.</p><p><strong>Option B &amp; C</strong>: Bulk forming agents e.g. Bran and Ispaghula are very safe.</p><ul><li><strong><u>Key Takeaway</u></strong></li><li><strong>The repeated use of osmotic or saline purgatives causes hypokalemia and other fluid &amp; electrolyte disturbances.</strong></li></ul><p><strong>[Good to Know]</strong></p><p><strong>[Osmotic purgatives]</strong></p><p><strong>Reference:</strong> Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number:726</p>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Omeprazole</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Lansoprazole</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Esomeprazole</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Rabeprazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65 year old male patient with history of ongoing treatment for tuberculosis presented to medicine department with complaints of heart burn, abdominal fullness, belching and later diagnosed of having Gastro-esophageal reflux disease (GERD). Which of the following proton pump inhibitor can be safely given in this patient?</span></p>",
      "unique_key": "Q238038",
      "question_audio": null,
      "question_video": null,
      "map_id": 238038,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong>Proton pump inhibitors are metabolized by CYP3A4 and CYP2C19</strong>. They are also <strong>inhibitors of these enzymes</strong>.</li><li><strong><u>Rabeprazole and pantoprazole has less affinity for these enzymes</u></strong>.</li></ul><p><strong><u>Rabeprazole </u></strong></p><ul><li>This drug is claimed to <strong>cause faster acid suppression</strong>.</li><li>Due to <strong>higher pKa, it is more rapidly converted to the active species.</strong></li><li>However, potency and efficacy are similar to omeprazole. <strong><u>No significant drug interactions have been observed.</u></strong></li></ul><p><strong>Option A, B &amp; C: </strong>All others drugs ar<strong>e significant inhibitors of </strong><strong>CYP3A4 and CYP2C19</strong> enzymes</p><p><strong><u>Key Takeaway</u></strong></p><ul><li>Proton pump inhibitors are metabolized by CYP3A4 and CYP2C19. They are also inhibitors of these enzymes. <u>Rabeprazole has less affinity for these enzymes</u>.</li></ul><p>[Must Know]</p><p>[Rabeprazole]</p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 701</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Cisapride</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Domperidone</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Ondansetron</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 78 year old patient with history of Parkinson's disease was prescribed Levodopa without carbidopa out of negligence. Later he came to medicine department with excessive vomiting. Which of the following antiemetic selectively blocks levodopa induced vomiting without blocking its anti-parkinsonian action?</span></p>",
      "unique_key": "Q238039",
      "question_audio": null,
      "question_video": null,
      "map_id": 238039,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><u>Domperidone </u></strong></li><li>It is a D<sub>2</sub> receptor antagonist, chemically related to haloperidol, but pharmacologically related to metoclopramide.</li></ul><ul><li>The antiemetic and prokinetic actions have a lower ceiling (less efficacious). Unlike metoclopramide, its prokinetic action is based only on D<sub>2</sub> receptor blockade in upper g.i.t., and is not attenuated by atropine.</li></ul><ul><li>Domperidone crosses blood-brain barrier poorly. Accordingly, extrapyramidal side effects are rare, but hyperprolactinaemia can occur.</li></ul><ul><li>The antiemetic action is exerted mainly through CTZ which is not protected by blood-brain barrier.</li></ul><ul><li><u>Because of poor entry into CNS, it does not block the therapeutic effect of levodopa in parkinsonism, but counteracts its dose-limiting emetic action.</u></li></ul><p><strong>Option A: Metoclopramide is also a D2 blocker but crosses the BBB, thus inhibiting the antiparkinsonian effects of Levodopa.</strong></p><p><strong>Option B: Cisapride, a 5HT4 agonist has no effect on D2 receptors</strong></p><p><strong>Option D: Ondansetron,a 5HT3 antagonist has no effect on D2 receptors </strong></p><p><strong><u>Key Takeaway</u></strong></p><ul><li>Domperidone because of its poor entry into CNS, it does not block the therapeutic effect of levodopa in parkinsonism, but counteracts its dose-limiting emetic action.</li></ul><p><strong>[Must Know]</strong></p><p><strong>[Domperidone]</strong></p><p>Reference: Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 715</p>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Sucralfate</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoclopramide</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Scopolamine</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 63 year old man with long-standing, poorly controlled diabetes is admitted for yet another episode of ketoacidosis. Now that he is out of the intensive care unit and beginning to eat, he complains of regurgitation of food following even small meals. You suspect the development of diabetic gastropathy, a consequence of his autonomic neuropathy. Which of the following might help his condition?</span></p>",
      "unique_key": "Q238040",
      "question_audio": null,
      "question_video": null,
      "map_id": 238040,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><em>Poor gastric emptying is a manifestation of the neuropathy that accompanies long-standing diabetes.</em></li></ul><ul><li>Metoclopramide <strong><em>increases lower esophageal sphincter tone by directly blocking dopamine D2 receptors</em></strong> and <em><u>increasing acetylcholine release, thereby activating muscarinic receptors in esophageal muscle</u></em>.</li></ul><ul><li><em>Metoclopramide acts through both dopaminergic and serotonergic Receptors</em></li></ul><p><strong><u>Metoclopramide blocks D2 receptors and causes</u></strong></p><ul><li><strong><em>Hastening gastric emptying and </em></strong></li><li><strong><em>Enhancing lower oesophageal sphincture tone by augmenting ach release.</em></strong></li></ul><p><strong><u>(b) <em>5-HT4 agonism</em></u></strong></p><p>Metoclopramide acts in the g.i.t. to enhance ACh release from myenteric motor neurones.</p><p><strong><em>The gastric hurrying and LES tonic effects of metoclopramide are mainly due to this action which is synergised by bethanechol and attenuated by atropine.</em></strong></p><ul><li><strong><em><u>Uses</u></em></strong></li></ul><ol><li><strong><em><u> Antiemetic: </u></em></strong></li></ol><ul><li><em>Metoclopramide is an effective and popular drug for many types of vomiting&mdash;postoperative, drug induced, disease associated (especially migraine), radiation sickness, etc, but is less effective in motion sickness</em>.</li></ul><ol start=\"2\"><li><strong><em><u> Gastrokinetic: To accelerate gastric emptying:</u></em></strong></li></ol><p><em>(a) When emergency general anaesthesia has to be given and the patient has taken food less than 4 hours before.</em></p><p><em>(b) To relieve postvagotomy or diabetic gastroparesis associated gastric stasis.</em></p><ol start=\"3\"><li><strong><em><u> Dyspepsia and other functional g.i. disorders:</u></em></strong></li></ol><ul><li><em>Metoclopramide may succeed in stopping persistent hiccups.</em></li></ul><ol start=\"4\"><li><strong><em><u> Gastroesophageal reflux disease (GERD)</u></em></strong></li></ol><ul><li><em>Metoclopramide may benefit milder cases of GERD, but is much less effective than PPIs/H2 blockers</em></li></ul><p><strong><em>Option A, C &amp; D</em></strong><em>: Sucralfate, scopolamine, and misoprostol are used to treat gastric ulcers. </em></p><ul><li><strong><u>Key Takeaway</u></strong></li><li><em>Prokinetic drugs like metoclopramide <strong>increases lower esophageal sphincter tone by directly blocking dopamine D2 receptors responsible for effect in GERD patients.</strong></em></li></ul><p><strong>[Good to Know]</strong></p><p><strong>[Metoclopramide]</strong></p><p><strong>Reference: </strong><strong>Essentials of Medical Pharmacology by KD Tripathi</strong> <strong>8<sup>th </sup>edition, page number. 713</strong></p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">M3 cholinergic</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">NN cholinergic</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">H2 histaminergic</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">D2 dopaminergic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50 year old woman brought to surgical outpatient department with complaints of regurgitation of foul-tasting fluid into her mouth and occasional nausea and vomiting. The physician prescribed a drug that can both prevent nausea and vomiting and promote upper gastrointestinal motility. Blockade of which of the following receptors most likely contributed to the therapeutic effect of the drug in the patient's disease?</span></p>",
      "unique_key": "Q238041",
      "question_audio": null,
      "question_video": null,
      "map_id": 238041,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><em>Metoclopramide is a dopamine D2 receptor antagonist, a serotonin 5-HT3 receptor antagonist, and a serotonin 5-HT4 receptor agonist.</em></li><li><em>In the enteric nervous system, all of these molecular actions seem to contribute to the final effect that is related to an increased activity of cholinergic motor neurons.</em></li><li>Metoclopramide <strong><em>increases lower esophageal sphincter tone by directly blocking dopamine D2 receptors</em></strong> and <em><u>increasing acetylcholine release, thereby activating muscarinic receptors in esophageal muscle</u></em>.</li></ul><p><em><u>Metoclopramide acts through both dopaminergic and serotonergic Receptors</u></em></p><p><strong><u>(a) <em>D2 antagonism </em></u></strong></p><p>Dopamine (acting through D2 receptors) is an <u>inhibitory transmitter in the</u> <u>g.i.t. </u></p><ul><li><u>Delays gastric emptying. </u></li><li><u>Causes gastric dilatation and</u></li><li><u>Lower oesophageal sphincture relaxation attending nausea and vomiting.</u></li></ul><p><strong><u>Metoclopramide blocks D2 receptors and has an opposite effect-</u></strong></p><ul><li><strong><em>Hastening gastric emptying and </em></strong></li><li><strong><em>Enhancing lower oesophageal sphincture tone by augmenting ach release.</em></strong></li></ul><p>The <strong><em>central antidopaminergic (D2) action of metoclopramide on CTZ is clearly responsible for its antiemetic property</em></strong>.</p><p><strong><u>(b) <em>5-HT4 agonism</em></u></strong></p><p>Metoclopramide acts in the g.i.t. to enhance ACh release from myenteric motor neurones.</p><p><strong><u>(c) <em>5-HT3 antagonism </em></u></strong></p><p><strong><em>At high concentrations metoclopramide can block 5-HT3</em></strong> receptors present on inhibitory myenteric interneurons and in the NTS/CTZ.</p><ul><li><strong><u>Key Takeaway</u></strong></li><li><strong><em>Prokinetic drugs like metoclopramide increases lower esophageal sphincter tone by directly blocking dopamine D2 receptors responsible for effect in GERD patients.</em></strong></li></ul><p><strong>[Must Know]</strong></p><p><strong>[Metoclopramide]</strong></p><p><strong>Reference: Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number. 713</strong></p>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhaled albuterol</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral triamcinolone</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhaled ipratropium</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhaled salmeterol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 15 year old boy was recently diagnosed with mild seasonal asthma. The boy was otherwise healthy and was a member of his school basketball team. Which of the following drugs would be most appropriate for the initial treatment of the patient's disease?</span></p>",
      "unique_key": "Q238042",
      "question_audio": null,
      "question_video": null,
      "map_id": 238042,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Inhaled short-acting &beta;2 agonists are considered first-line drugs for the treatment of asthma.</em></strong></li></ul><ul><ul><li><em><u>According to current guidelines, a short-acting &beta;2 agonist should be given as needed to all patients with asthma.</u></em><em> Because the patient&rsquo;s asthma is mild, inhaled albuterol as needed is most likely the preferred drug.</em></li><li><strong><em>Inhaled albuterol would provide the fastest acting and most localized</em></strong> <strong><em>therapy for an acute attack.</em></strong></li></ul></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/PharmacoMiniII27112024/12E.jpg\"><ul><li><strong><em>Bronchodilators </em></strong><strong><em>are the <u>only drugs useful in terminating acute attack of bronchial asthma. </u></em></strong></li></ul><p><strong><em>Adrenergic drugs (&beta;2 agonists) act by:</em></strong></p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/PharmacoMiniII27112024/12E1.jpg\"><ul><li>By <u>inhalational route</u>, these are the <strong>fastest acting drugs</strong>.</li></ul><p><strong>Option B</strong>: <em>Oral steroids are administered only in case of severe asthma that is not controlled by other antiasthmatic drugs</em></p><p><strong>Option C:</strong> <em>Ipratropium alone is not used for the treatment of asthma. It can be used with albuterol in severely ill patients where it has been shown to improve pulmonary function.</em></p><p><strong>Option D:</strong>&nbsp; <em>Salmeterol is a long-acting &beta;2 agonist. Combination products containing a long-acting &beta;2 agonist with an inhaled steroid can retain current indications, including asthma, as an increased risk of asthma-related complications was not demonstrated with this combination.</em></p><ul><li><strong><u>Key Takeaway</u></strong><ul><li><strong><em>Inhaled albuterol would provide the fastest acting and most localized</em></strong> <strong><em>therapy for an acute attack.</em></strong></li></ul></li></ul><p><strong>[Must Know]</strong></p><p><strong>[Albuterol]</strong></p><p><strong>Reference: </strong><strong>Essentials of Medical Pharmacology by KD Tripathi</strong> <strong>8<sup>th </sup>edition, page number. 242</strong></p>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Azithromycin</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythromycin</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45 years old male patient has history of chronic asthma is ongoing treatment with Theophylline. Later he developed upper respiratory tract infection with mild pneumonitis. Which of the following is the most suitable option to safely treat his upper respiratory tract infection without compromising treatment of asthma?</span></p>",
      "unique_key": "Q238043",
      "question_audio": null,
      "question_video": null,
      "map_id": 238043,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>Azithromycin has been found not to affect hepatic CYP3A4 enzyme</em></strong>. <strong><em>Hence it can safely be given along side of theophylline to treat respiratory tract infections.</em></strong></li></ul><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/PharmacoMiniII27112024/13E.jpg\"><ul><li><strong><u>Mnemonic</u></strong></li></ul><p><strong><u>Enzyme inhibitors </u></strong><strong>[ <em>Virat Kohli Can&rsquo;t Call Every Indians</em>]</strong></p><p><strong><u>V</u></strong>alproate</p><p><strong><u>K</u></strong>etoconazole</p><p><strong><u>C</u></strong>imetidine</p><p><strong><u>C</u></strong>iprofloxacin/<strong><u>C</u></strong>larithromycin</p><p><strong><u>E</u></strong>rythromycin</p><p><strong><u>I</u></strong>NH</p><p><strong>Option A, C &amp; D: </strong><em>All these given options are cytochrome enzyme inducers/inhibitors and hence they increase/decrease the metabolism of Theophylline&nbsp; causing therapeutic failure/toxicity of the same.</em></p><ul><li><strong><em><u>Key Takeaway</u></em></strong></li><li><strong><em>Azithromycin has been found not to affect hepatic CYP3A4 enzyme. Interaction with theophylline, carbamazepine, warfarin, terfenadine and cisapride is not likely, but caution may be exercised.</em></strong></li></ul><p><strong>[Must Know]</strong></p><p><strong>[</strong><strong>Azithromycin</strong><strong>]</strong></p><p><strong><em><strong>Reference: Essentials of Medical Pharmacology by KD Tripathi 8<sup>th </sup>edition, page number:246,805</strong></em></strong></p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Anticholinergic inhaler</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Leukotriene receptor antagonist</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Lipoxygenase inhibitor</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Methylxanthines</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 19 year old female with severe persistent asthma is placed on multiple medications. She has been taking her medications as instructed but one day she again brought back to chest clinic with complaints of tachycardia, nausea, and jitteriness suspected to be due to side effect of one of the prescribed medicine. She has been informed of the need to measure serum levels of this medication. Which of the following medication is responsible for the above given undesirable side effects?</span></p>",
      "unique_key": "Q238044",
      "question_audio": null,
      "question_video": null,
      "map_id": 238044,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><strong><em>The methylxanthine agent is given in asthma because of its <u>prominent bronchodilatory effect.</u></em></strong></li><li><strong><em>These agents have a <u>low therapeutic index and often can cause adverse effects.</u></em></strong></li><li><strong><em>Narrow therapeutic index drug has low safety of margin</em></strong>. Hence, it <strong><em>requires monitoring of blood levels -Therapeutic drug monitoring.</em></strong></li><li>Normal therapeutic range: <strong><em>5-15 mg/dl</em></strong></li><li>It is degraded by <strong><em>CYP1A2.</em></strong></li></ul><p><strong><u>Side effects: </u></strong></p><p><strong><em>Mnemonic [DSP having Nausea]</em></strong></p><ul><li><strong>D</strong>iuresis</li><li><strong>S</strong>eizures</li><li><strong>P</strong>alpitation and arrhythmias</li><li><strong>N</strong>ausea/vomiting/diarrhea</li><li><strong>P</strong>ulsatile headache.</li></ul><p><strong>Option A: </strong><em>Ipratropium bromide </em><em>is a short acting inhaled anticholinergic bronchodilator, Administered as aerosol, they produce minimal antimuscarinic&nbsp;</em><em>side effects due to poor systemic absorption.</em></p><p><strong>Option B: </strong><em>Montelukast and zafirlukast are very safe drugs; produce few side effects like abdominal pain, headache and rashes</em></p><p><strong>Option C: </strong><em>Zileuton(</em>Lipoxygenase inhibitor<em>) </em><em>inhibits synthesis of LTB4 (chemotactic) and LTC4 and LTD4 (bronchoconstrictor). Limiting features of this drug are short duration of action and </em><em>hepatotoxicity</em><em>.</em></p><ul><li><strong><u>Key Takeaway</u></strong></li><li><strong><em>Methylxanthines directly stimulate the heart and increase force of myocardial contractions. They tend to increase heart rate</em></strong></li></ul><p><strong>[Good to Know]</strong></p><p><strong>[Methylxanthines]</strong></p><p><strong>Reference: </strong><strong>Essentials of Medical Pharmacology by KD Tripathi</strong> <strong>8<sup>th </sup>edition, page number. 246</strong></p>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Theophylline</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoproterenol</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Salmeterol</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Zileuton</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34 year old woman was brought to chest physician with episodes of shortness of breath and cough along with an upper respiratory infection. She also gave history of night time awakening. Spirometry showed a forced expiratory volume (FEV1) 62% of the predicted value. Which of the following drugs would be most appropriate included in the patient's treatment at this time?</span></p>",
      "unique_key": "Q238045",
      "question_audio": null,
      "question_video": null,
      "map_id": 238045,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000005
      ],
      "solution": "<ul><li><em><u>Forced expiratory volume (FEV1) is one of the best indicators of the severity of a bronchospastic disorder.</u></em></li><li><em>FEV1 between 60 and 80% of the predicted value indicates moderate disease. </em></li><li><em>Because the patient&rsquo;s symptoms occurred daily, her asthma can be classified <strong>as moderate persistent.</strong> </em></li><li><strong><em>The preferred treatment for moderate persistent asthma is a low to medium dose of inhaled corticosteroids and a long-acting inhaled &beta;2 agonist such as salmeterol daily, plus a short-acting inhaled &beta;2 agonist such as albuterol, as needed</em></strong><em>.</em></li><li><strong><em><u>Salmeterol </u></em></strong></li><li><strong><em>It is the first long acting selective </em></strong><strong><em>&beta;</em></strong><strong><em>2 agonist with a slow onset of action which is used by inhalation on a twice daily schedule for maintenance therapy, as well as for nocturnal asthma, but not for acute symptoms. </em></strong></li><li><em>It is more </em><em>&beta;</em><em>2 selective than salbutamol, as well as more lipophilic which probably accounts for its <strong>longer duration of action.</strong> </em></li><li><strong><em>Combined use of inhaled salmeterol with inhaled glucocorticoid produces effects equivalent to double dose of the corticosteroid alone. </em></strong></li><li><em>It is now advocated that<strong> long-acting </strong></em><strong><em>&beta;</em></strong><strong><em>2 agonists should be used only in combination with an inhaled steroid.</em></strong></li></ul><p><strong>Option A</strong>: <em>Theophylline is very rarely used today for the therapy of asthma.</em></p><p><strong>Option B</strong>: <em>This drug, used in the past, is now obsolete.</em></p><p><strong>Option D</strong>: <em>Zileuton is not a preferred choice. It is used as an add on drug in resistant cases</em></p><ul><li><strong><u>Key Takeaway</u></strong></li><li><strong><em>Salmeterol is long acting selective </em></strong><strong><em>&beta;</em></strong><strong><em>2 agonist with a slow onset of action which is used by inhalation for maintenance therapy, as well as for nocturnal asthma, but not for acute symptoms.</em></strong></li></ul><p><strong>[Good to Know]</strong></p><p><strong>[Salmeterol]</strong></p><p><strong>Reference: </strong><strong>Essentials of Medical Pharmacology by KD Tripathi</strong> <strong>8<sup>th </sup>edition, page number. 243</strong></p>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}